Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 308Active not recruiting 182Not yet recruiting 80Completed 79Terminated 17Enrolling by invitation 13Withdrawn 7Suspended 5Available 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 5Plasma cell 1Gastrointestinal 1Breast 1

Conditions

Glioblastoma 10Breast Neoplasms 10Neoplasms 9Leukemia, Myeloid, Acute 9Neoplasm Metastasis 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Prostatic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Myelodysplastic Syndromes 5Lung Neoplasms 5Hematologic Neoplasms 5Ovarian Neoplasms 4Multiple Myeloma 4Glioma 4Uterine Cervical Neoplasms 3Sarcoma 3Melanoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Astrocytoma 3Triple Negative Breast Neoplasms 2Solid Tumors 2Solid Tumor 2Recurrence 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2

Interventions

Watchful Waiting 1Specimen Handling 1Observation 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × 90 days × Clear all
NCT04519879 2026-06-03

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

City of Hope Medical Center

Phase 2 Suspended
133 enrolled
Genitourinary

Prostatic Neoplasms

NCT04981834 2026-06-01

Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer

University of Southern California

Phase NA Suspended
196 enrolled
Genitourinary

Prostatic Neoplasms

NCT07146113 2026-05-29

PRIME

AstraZeneca

Suspended
400 enrolled
Genitourinary

Prostatic Neoplasms

NCT04955808 2026-05-13

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

National Cancer Institute (NCI)

Suspended
2,400 enrolled
BreastGastrointestinalGenitourinaryPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Multiple Myeloma, Prostatic Neoplasms

NCT05362032 2026-05-04

Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate

OHSU Knight Cancer Institute

Phase NA Suspended
45 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡